Encompass Health EHC
$133.65 +$1.37 (+1.04%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $133.65 0.00%
Open$133.60
Prev close$132.28
Day range$132.55 – $134.84
Volume911.9K
Market cap$13.11B
P/E (TTM)20.9
Dividend yield0.58%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$1.61B+8.9% YoY
Operating profit$288.00M+18.2% YoY
Net profit$203.60M+16.6% YoY
Diluted EPS$1.50+21.0% YoY
Free cash flow$127.50M+52.3% YoY
Operating cash flow$362.00M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin95.9%
Operating margin18.3%
Net margin10.1%
Return on equity25.4%
Return on assets8.9%
Return on invested capital14.1%
Current ratio1.09
Liabilities / assets52.9%
Cash & investments$76.20M
Total debt$2.78B
Net cash (debt)-$2.70B
Free cash flow / sales7.2%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $1.61B | $1.60B | $1.59B | $5.94B | $1.54B |
| Total Operating Revenue | $1.61B | $1.60B | $1.59B | $5.94B | $1.54B |
| Cost of Revenue | $65.00M | $66.10M | $64.30M | $254.40M | $64.50M |
| Gross Profit | $1.54B | $1.53B | $1.52B | $5.68B | $1.48B |
| Operating Expense | $1.26B | $1.24B | $1.22B | $4.63B | $1.20B |
| Selling and Admin Expenses | $915.60M | $897.60M | $891.50M | $3.41B | $884.00M |
| -General & Admin Expense | $915.60M | $897.60M | $891.50M | $3.41B | $884.00M |
| Depreciation & Amortization & Depletion | $95.70M | $90.40M | $87.30M | $327.90M | $86.40M |
| -Depreciation & Amortization | $95.70M | $90.40M | $87.30M | $327.90M | $86.40M |
| Other Operating Expenses | $245.20M | $254.90M | $241.90M | $888.70M | $226.30M |
| Operating Profit | $288.00M | $288.40M | $301.60M | $1.05B | $283.40M |
| Net Non-Operating Interest Income (Expense) | -$32.20M | -$32.80M | -$31.80M | -$123.20M | -$30.20M |
| Non-Operating Interest Expense | $32.20M | $32.80M | $31.80M | $123.20M | $30.20M |
| Other Income (Expense) | $2.00M | $6.00M | $18.90M | $23.10M | $4.50M |
| Earnings from Equity Interest | $100,000.00 | $100,000.00 | $400,000.00 | $4.30M | $800,000.00 |
| Special Income (Charges) | $0.00 | -$3.20M | -$200,000.00 | $0.00 | $0.00 |
| Other Non-Operating Income (Expenses) | $1.90M | $9.10M | $18.70M | $18.80M | $3.70M |
| Pretax Profit | $257.80M | $261.60M | $288.70M | $953.00M | $257.70M |
| Tax | $53.40M | $53.60M | $56.40M | $192.90M | $55.40M |
| Net Profit | $203.60M | $207.40M | $248.20M | $759.10M | $203.10M |
| Profit from Continuing Operations | $204.40M | $208.00M | $232.30M | $760.10M | $202.30M |
| Net Income from Discontinuous Operations | -$800,000.00 | -$600,000.00 | $15.90M | -$1.00M | $800,000.00 |
| Minority Interests | $53.70M | $53.50M | $53.70M | $192.90M | $57.00M |
| Net Income to Parent Company | $149.90M | $153.90M | $194.50M | $566.20M | $146.10M |
| Net Income to Common Stockholders | $149.90M | $153.90M | $194.50M | $564.70M | $144.60M |
| Basic EPS | $1.52 | $1.55 | $1.96 | $5.62 | $1.45 |
| Diluted EPS | $1.50 | $1.54 | $1.93 | $5.54 | $1.43 |
| Dividend Per Share | $0.21 | $0.19 | $0.19 | $0.72 | $0.19 |
| -Less:Other Special Charges | – | $3.20M | $200,000.00 | – | – |
| Other Preferred Stock Dividends | – | – | – | $1.50M | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $7.57B | $7.46B | $7.31B | $7.09B | $7.09B |
| Total Current Assets | $1.01B | $1.04B | $1.03B | $905.90M | $905.90M |
| Cash and Cash Equivalents & Short-Term Investments | $76.20M | $107.70M | $110.50M | $72.20M | $72.20M |
| -Cash and Cash Equivalents | $76.20M | $107.70M | $110.50M | $72.20M | $72.20M |
| Receivables | $712.00M | $687.30M | $676.00M | $619.20M | $619.20M |
| -Accounts Receivable | $712.00M | $687.30M | $676.00M | $619.20M | $619.20M |
| Restricted Cash | $24.00M | $25.80M | $52.90M | $30.70M | $30.70M |
| Other Current Assets | $200.80M | $220.20M | $189.70M | $129.90M | $129.90M |
| Total Non-Current Assets | $6.55B | $6.42B | $6.28B | $6.18B | $6.18B |
| Net PPE | $4.67B | $4.54B | $4.42B | $4.31B | $4.31B |
| -Gross PPE | $4.67B | $4.54B | $4.42B | $6.69B | $6.69B |
| Goodwill and Other Intangible Assets | $1.63B | $1.63B | $1.62B | $1.63B | $1.63B |
| -Goodwill | $1.32B | $1.32B | $1.32B | $1.32B | $1.32B |
| -Other Intangible Assets | $301.50M | $306.80M | $300.30M | $308.30M | $308.30M |
| Other Non-Current Assets | $256.40M | $246.30M | $244.40M | $243.70M | $243.70M |
| Total Liabilities | $4.01B | $4.00B | $3.95B | $3.81B | $3.81B |
| Total Current Liabilities | $927.40M | $873.40M | $876.80M | $836.40M | $836.40M |
| Payables | $231.40M | $221.60M | $204.00M | $233.00M | $233.00M |
| -Accounts Payable | $231.40M | $221.60M | $204.00M | $178.20M | $178.20M |
| Current Accrued Expenses | $620.20M | $588.40M | $603.00M | $243.70M | $243.70M |
| Short-Term Debt and Capital Lease Obligation | $75.80M | $63.40M | $69.80M | $70.10M | $70.10M |
| -Current Debt | $47.80M | $35.90M | $42.90M | $43.60M | $43.60M |
| -Current Capital Lease Obligation | $28.00M | $27.50M | $26.90M | $26.50M | $26.50M |
| Total Non-Current Liabilities | $3.08B | $3.12B | $3.07B | $2.98B | $2.98B |
| Long Term Debt and Capital Lease Obligation | $2.73B | $2.78B | $2.72B | $2.64B | $2.64B |
| -Long Term Debt | $2.55B | $2.60B | $2.53B | $2.45B | $2.45B |
| -Long Term Capital Lease Obligation | $176.30M | $180.80M | $188.70M | $196.60M | $196.60M |
| Non-Current Deferred Liabilities | $127.50M | $131.90M | $135.10M | $126.80M | $126.80M |
| Other Non-Current Liabilities | $222.80M | $212.20M | $214.50M | $206.90M | $206.90M |
| Total Equity | $3.56B | $3.46B | $3.37B | $3.28B | $3.28B |
| Stockholders' Equity | $2.68B | $2.60B | $2.52B | $2.44B | $2.44B |
| Capital Stock | $1.20M | $1.20M | $1.20M | $1.20M | $1.20M |
| -Common Stock | $1.20M | $1.20M | $1.20M | $1.20M | $1.20M |
| Additional Paid-In Capital | $1.89B | $1.87B | $1.86B | $1.87B | $1.87B |
| Retained Earnings | $1.73B | $1.60B | $1.46B | $1.29B | $1.29B |
| Less: Treasury Stock | -$934.90M | -$875.80M | -$804.70M | -$722.50M | -$722.50M |
| Gains/Losses Not Affecting Retained Earnings | -$2.10M | -$400,000.00 | -$200,000.00 | $500,000.00 | $500,000.00 |
| Minority Interests | $880.00M | $863.40M | $845.50M | $837.60M | $837.60M |
| Prepaid Assets | – | – | – | $53.90M | $53.90M |
| -Accumulated Depreciation | – | – | – | -$2.37B | -$2.37B |
| -Dividends Payable | – | – | – | $54.80M | $54.80M |
| Other Current Liabilities | – | – | – | $289.60M | $289.60M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $362.00M | $282.60M | $313.10M | $1.18B | $346.00M |
| Net cash flow from continuing operations | $363.10M | $283.50M | $291.90M | $1.18B | $344.90M |
| Net Income from Continuing Operations | $204.40M | $208.00M | $232.30M | $760.10M | $202.30M |
| Gain/Loss from Continuing Operations | $800,000.00 | -$3.00M | -$16.20M | -$4.30M | $1.80M |
| Depreciation & Depletion & Amortization | $95.70M | $90.40M | $87.30M | $327.90M | $86.40M |
| Deferred Tax | -$3.80M | -$3.10M | $8.50M | $22.30M | $19.10M |
| Other Non-Cash Items | $2.90M | $4.50M | $2.30M | $6.10M | -$1.10M |
| Change in Working Capital | $48.10M | -$27.10M | -$33.80M | $4.30M | $13.90M |
| -Change in Receivables | -$26.10M | -$10.20M | -$53.20M | -$15.20M | $3.60M |
| -Change in Payables and Accrued Expense | $31.10M | $22.30M | -$2.00M | -$6.70M | $35.40M |
| -Change in Other Current Assets | $7.60M | -$16.80M | -$11.60M | – | – |
| -Change in Other Current Liabilities | $35.50M | -$22.40M | $33.00M | $57.40M | -$13.40M |
| Cash Flow from Discontinued Operating Activities | -$1.10M | -$900,000.00 | $21.20M | -$1.40M | $1.10M |
| Net cash flow from investing | -$241.60M | -$235.60M | -$150.10M | -$764.60M | -$239.40M |
| Net Cash Flow from Continuing Investing Activities | -$241.60M | -$235.60M | -$150.10M | -$764.60M | -$239.40M |
| Net PPE Purchase and Sale | -$234.50M | -$220.30M | -$162.40M | -$736.40M | -$229.30M |
| Net Other Investing Changes | -$7.10M | -$15.30M | $12.30M | -$28.20M | -$10.10M |
| Financing Cash Flow | -$153.70M | -$76.90M | -$102.50M | -$431.20M | -$97.40M |
| Net Cash Flow from Continuing Financing Activities | -$153.70M | -$76.90M | -$102.50M | -$431.20M | -$97.40M |
| Net Issuance Payments Of Debt | -$35.70M | $55.30M | $90.00M | -$29.00M | $41.90M |
| Net Common Stock Issuance | -$57.90M | -$74.20M | -$71.60M | -$158.00M | -$76.30M |
| Cash Dividends Paid | -$18.70M | -$18.90M | -$20.30M | -$71.10M | -$19.00M |
| Net Other Financing Charges | -$41.40M | -$39.10M | -$100.60M | -$173.10M | -$44.00M |
| Ending Cash Balance | $100.20M | $133.50M | $163.40M | $102.90M | $102.90M |
| Net Change in Cash | -$33.30M | -$29.90M | $60.50M | -$20.20M | $9.20M |
| Beginning Cash Balance | $133.50M | $163.40M | $102.90M | $123.10M | $93.70M |
| Free Cash Flow | $127.50M | $62.30M | $150.70M | $439.20M | $116.70M |
| -Change in Prepaid Assets | – | – | – | -$31.20M | – |
No comments yet — be the first to weigh in on EHC.
Sign in to join the discussion.